Moorkens, Evelien http://orcid.org/0000-0002-9570-470X
Vulto, Arnold G. http://orcid.org/0000-0002-8439-2800
Kent, James
McClure, Lindsay
Boldero, Richard
Vanhove, Thibault
Simoens, Steven http://orcid.org/0000-0002-9512-2005
Huys, Isabelle http://orcid.org/0000-0002-4738-8298
Funding for this research was provided by:
University Medical Center Rotterdam
Article History
First Online: 11 December 2020
Declarations
:
: This manuscript is supported by KU Leuven and the Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL). The Open Access fee was covered via the Open Access Agreement with the Erasmus University Medical Center Rotterdam.
: SS, IH and AGV are founders of the KU Leuven Fund on Market Analysis of Biologics and Biosimilars following Loss of Exclusivity (MABEL). SS, IH and AV have conducted biosimilar research sponsored by Hospira (now Pfizer). SS was involved in a stakeholder roundtable on biologics and biosimilars sponsored by Amgen, Pfizer and MSD; he has participated in advisory board meetings for Pfizer and Amgen; and he has contributed to studies on biologics and biosimilars for Celltrion, Mundipharma and Pfizer. AV is involved in consulting, advisory work and speaking engagements for a number of companies, a.o. AbbVie, Accord Healthcare, Amgen, Biogen, Fresenius-Kabi, Medicines for Europe, Pfizer/Hospira, Mundipharma, Roche, Samsung/Bioepis, Sandoz/Novartis. EM, JK, RB, LM and TV declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.
: The market data used in this study are available from the corresponding author on reasonable request.
: Not applicable.
: The interview guide and methodology for this study (MP006423) was approved by the Research Ethics Committee UZ/KU Leuven on 28 August 2018.
: IH, AV, SS and EM developed the idea for and were involved in the design of this study. EM, JK, RB, LM and TV were involved in data collection. EM drafted the initial version of the manuscript. IH, AV, SS, JK, RB, LM and TV critically reviewed the manuscript. All authors read and approved the final manuscript.
: Informed consent was obtained from all individual participants included in the study.
: Informed consent was obtained from all individual participants included in the study.